SOBI:STO
Swedish Orphan Biovitrum AB (publ)
427,20 SEK
arrow_downward
-1,48%(-6,40) 1D
13 ოქტ, 17:29:57 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
433,60 SEK
High
437,40 SEK
Low
420,40 SEK
Mkt. cap
152,78 მლრ.
Avg. vol.
269,95 ათ.
Volume
332,11 ათ.
P/E ratio
114,10
52-wk high
487,00 SEK
52-wk low
293,60 SEK
EPS
3,74 SEK
Shares outstanding
357,64 მლნ.
No. of employees
2 ათ.
Open
433,60 SEK
High
437,40 SEK
Low
420,40 SEK
Mkt. cap
152,78 მლრ.
Avg. vol.
269,95 ათ.
Volume
332,11 ათ.
P/E ratio
114,10
52-wk high
487,00 SEK
52-wk low
293,60 SEK
EPS
3,74 SEK
Shares outstanding
357,64 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
Yahoo Finance
·
1 დღის წინ
Earnings Preview: Swedish Orphan Biovitrum (BIOVF) Q3 Earnings Expected to Decline
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)